For citations:
Chizh G.A., Rykov I.V., Orlova D.S. Are there arguments for CDK4/6 inhibitors in visceral crisis in metastatic luminal breast cancer? Review of recent data and presentation of the clinical case. Clinical Case in Oncology. 2025;3(1):27-34. (In Russ.) https://doi.org/10.62546/3034-1477-2025-3-1-27-34
Email this article 